Back to results
US 2019/0240268 A1Published application
Infection protective agent for infants
AssigneesMeiji Co., Ltd., Shiga University of Medical Science
InventorsShigeki KOSHIDA, Masaki TERAHARA
Life of this patent
Estimating the term…
Abstract
Provided herein is an infection protective agent for ameliorating infections in infants, particularly newborns, without causing side effects. The infection protective agent for infants of the present invention comprises a bifidobacterium.
Claims20
A method for protecting against infection of an infant comprising orally administering a bifidobacterium to the infant,
- wherein the bifidobacterium is administered in an amount of 108 or more in terms of the number of bacteria per day continuously for at least 1 month to increase a serum IgG concentration of the infant,
- the infant is a healthy infant, an immature infant, a premature infant, or a low-birth-weight infant, and
- the infant is a child of newborn to less than one year age.
A method for protecting against infection of an infant comprising orally administering a bifidobacterium to the infant,
- wherein the bifidobacterium is administered in an amount of 108 or more in terms of the number of bacteria per day continuously for at least 1 month to increase a serum IgG concentration and a gut IgA concentration of the infant,
- the infant is a healthy infant, an immature infant, a premature infant, or a low-birth-weight infant, and
- the infant is a child of newborn to less than one year age.
Dependencies are inferred from the claim text.